Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Thai patients to receive free HIV drugs, regardless of CD4 count

    The Thai Public Health Ministry has started distributing free antiretroviral drugs to all HIV patients in a move to expand treatment coverage and place them under the state's monitoring system. Previously, HIV patients would receive the drugs only if their number of CD4 cells — which mark the presence of HIV antibodies — decreased to 350, compared with 500 in normal people. From Wednesday, all HIV patients would have access to the drugs without the need for a CD4 count, Deputy Public Health Minister Somsak Chunharas said on Wednesday.

    2 hours ago | Bangkok Post
  • Exclusive: India set to run out of critical free drug for HIV/AIDS program

    India could run out of a critical medicine in its free HIV/AIDS drugs program in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month.

    01 October 2014 | Reuters
  • UNITAID: Tuberculosis diagnostics technology and market landscape – 3rd edition

    UNITAID releases today its 2014 Tuberculosis Diagnostics Technology and Market Landscape, detailing the promising pipeline of products and technologies to diagnose tuberculosis (TB). The report highlights current and emerging technologies from over 80 manufacturers and developers, including products which are smaller, simpler and easier to use.

    01 October 2014 | EATG
  • Patent landscape for hepatitis issued by WHO

    The World Health Organization has published an analysis of the patent situation for new hepatitis treatments, and a call for possible pharmaceutical products for prequalification.

    29 September 2014 | Intellectual Property Watch
  • Countries ready to “Fast Track” response to end the AIDS epidemic by 2030

    High-level panel emphasizes fragile five-year window for rapid and massive acceleration of HIV treatment and prevention services. New agreement to reduce cost of viral load tests for HIV to below US$ 10 will improve the quality of life for millions of people on HIV treatment

    26 September 2014 | UNAIDS
  • Roche launches Global Access Program for HIV viral load testing

    To support the Global Access Program, Roche has committed to expanding access to its COBAS® AmpliPrep/COBAS TaqMan HIV-1 Test version 2.0 through a special pricing scheme for qualifying organizations in eligible countries.

    26 September 2014 | Roche press release
  • Why Gilead’s Recent Deal with Generic Producers for its Hepatitis C Drugs (Sofosbuvir and Ledipasvir) is a Sham

    Under the pretext of increasing access to its hepatitis C treatment, the new deal signed by Gilead for their HCV drugs sofosbuvir (Sovaldi©) and ledipasvir hides a clear strategy to prevent fair generic competition. The International Treatment Preparedness Coalition (ITPC) denounces Gilead’s strategy to block generic competition.

    25 September 2014 | ITPC
  • As Gilead Mulls Price of Next Hepatitis C Drug, Top Activist Refutes "Bogus" Math

    Sovaldi, the hepatitis C drug that costs US$1,000 a pill and US$84,000 for a full course of treatment, is about to look a little bit more reasonable by comparison. According to industry analysts, the price for Gilead's next hepatitis C drug (a combination of Sovaldi and the experimental drug ledipasvir), which the U.S. Food and Drug Administration may approve as soon as next month, could come with a price tag of US$95,000 for a course of treatment.

    24 September 2014 | TheBody.com
  • Hepatitis C: Sit in of European patients to request access to new medicines, on occasion of the informal meeting of European Health Ministers in Milan

    In support of the Call to EU Ministers of Health and CEOs of Abbvie, BMS, Gilead, Janssen and Merck/MSD regarding Universal Access to Curative Hepatitis C Treatment in the EU an beyond (attached), EPAC, Lila and Nadir with the support of the subscribers of the call, organized a “Sit-In” of people living with hepatitis C and their allies on the 22nd of September, at the Mico Conference Center, in Milan, starting at 11:20 am, to advocate for, and demand, a clear political and public health commitment and leadership from the twenty eight member states of the European Union

    22 September 2014 | EATG
  • Thousands register for new hepatitis C drug in Egypt sold at 99 percent discount

    On Thursday, Gamal Esmat, member of the Egyptian National Committee on Viral Hepatitis told Aswat Masriya that around 1,7000 people had registered hours after online registration opened on the Health Ministry’s website.

    19 September 2014 | Egyptian Streets
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.